Vasamed Stock Performance
| VSMD Stock | USD 0.0001 0.00 0.00% |
The entity has a beta of 0.0, which indicates not very significant fluctuations relative to the market. the returns on MARKET and Vasamed are completely uncorrelated.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days Vasamed has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound primary indicators, Vasamed is not utilizing all of its potentials. The current stock price tumult, may contribute to shorter-term losses for the shareholders. ...more
Vasamed |
Vasamed Relative Risk vs. Return Landscape
If you would invest 0.01 in Vasamed on September 29, 2025 and sell it today you would earn a total of 0.00 from holding Vasamed or generate 0.0% return on investment over 90 days. Vasamed is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of pink sheets are less volatile than Vasamed, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Vasamed Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Vasamed's investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as Vasamed, and traders can use it to determine the average amount a Vasamed's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| VSMD |
Based on monthly moving average Vasamed is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Vasamed by adding Vasamed to a well-diversified portfolio.
Vasamed Fundamentals Growth
Vasamed Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Vasamed, and Vasamed fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Vasamed Pink Sheet performance.
| Return On Asset | -0.74 | |||
| Profit Margin | (0.56) % | |||
| Operating Margin | (0.47) % | |||
| Current Valuation | 2.89 M | |||
| Price To Earning | (0.33) X | |||
| Price To Sales | 0.84 X | |||
| Revenue | 3.13 M | |||
| EBITDA | (1.47 M) | |||
| Cash And Equivalents | 136.82 K | |||
| Cash Per Share | 0.02 X | |||
| Total Debt | 1.8 M | |||
| Book Value Per Share | (2.10) X | |||
| Cash Flow From Operations | (2.34 M) | |||
| Earnings Per Share | (0.24) X | |||
| Total Asset | 1.56 M | |||
| Retained Earnings | (96.99 M) | |||
| Current Asset | 1.69 M | |||
| Current Liabilities | 1.55 M | |||
About Vasamed Performance
By analyzing Vasamed's fundamental ratios, stakeholders can gain valuable insights into Vasamed's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Vasamed has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Vasamed has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Vasamed Incorporated designs, licenses, manufactures, and distributes products, software, and services for assessing and managing hemodynamic health in the United States. The company was founded in 1988 and is headquartered in Eden Prairie, Minnesota. Vasamed operates under Medical Instruments Supplies classification in the United States and is traded on OTC Exchange.Things to note about Vasamed performance evaluation
Checking the ongoing alerts about Vasamed for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Vasamed help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Vasamed generated a negative expected return over the last 90 days | |
| Vasamed has some characteristics of a very speculative penny stock | |
| Vasamed has a very high chance of going through financial distress in the upcoming years | |
| Vasamed currently holds 1.8 M in liabilities. Vasamed has a current ratio of 0.32, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Vasamed until it has trouble settling it off, either with new capital or with free cash flow. So, Vasamed's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Vasamed sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Vasamed to invest in growth at high rates of return. When we think about Vasamed's use of debt, we should always consider it together with cash and equity. | |
| The entity reported the previous year's revenue of 3.13 M. Net Loss for the year was (2.92 M) with profit before overhead, payroll, taxes, and interest of 1.73 M. | |
| Vasamed currently holds about 136.82 K in cash with (2.34 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.02, which can makes it an attractive takeover target, given it will continue generating positive cash flow. |
- Analyzing Vasamed's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Vasamed's stock is overvalued or undervalued compared to its peers.
- Examining Vasamed's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Vasamed's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Vasamed's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Vasamed's pink sheet. These opinions can provide insight into Vasamed's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Vasamed Pink Sheet analysis
When running Vasamed's price analysis, check to measure Vasamed's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vasamed is operating at the current time. Most of Vasamed's value examination focuses on studying past and present price action to predict the probability of Vasamed's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vasamed's price. Additionally, you may evaluate how the addition of Vasamed to your portfolios can decrease your overall portfolio volatility.
| CEOs Directory Screen CEOs from public companies around the world | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Global Correlations Find global opportunities by holding instruments from different markets |